You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bladder transitional cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

Withdrawn
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • (no location specified)
Aug 8, 2022

Biomarkers in Bladder Urothelial Carcinoma

Completed
  • Bladder Cancer
  • Free glycosaminoglycan profiling
  • Gothenburg, Sweden
    Department of Urology, Institute of Clinical Science, Sahlgrensk
Apr 3, 2023

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

Not yet recruiting
  • Urinary Bladder Neoplasms
    • (no location specified)
    Feb 14, 2023

    Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)

    Not yet recruiting
    • Metastatic Urothelial Carcinoma
    • Pembrolizumab (200mg)
    • +2 more
    • (no location specified)
    Sep 18, 2023

    Hematuria, Urothelial Tumor, Urothelial Carcinoma Trial in Rotterdam (urine-first strategy)

    Recruiting
    • Hematuria
    • +3 more
    • urine-first strategy
    • Rotterdam, Netherlands
      SeARCH-trial Pijpers
    Aug 30, 2023

    Bladder Cancer Trial in Lausanne (Flexible cystoscopy, Urinary catheter)

    Active, not recruiting
    • Bladder Cancer
    • Flexible cystoscopy
    • Urinary catheter
    • Lausanne, VD, Switzerland
      Centre Hospitalier Universitaire Vaudois, CHUV
    Dec 1, 2022

    Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

    Not yet recruiting
    • Advanced Solid Tumor
    • +15 more
    • (no location specified)
    Jun 2, 2023

    Avelumab First-Line Maintenance in Canadian People With Advanced

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • +3 more
    • Avelumab first-line maintenance
    • Mississauga, Ontario, Canada
      Bayshore Specialty Rx
    Jan 24, 2023

    Liquid Biospy for Urinary Cancers

    Recruiting
    • Urothelial Carcinoma
    • Genetic analysis on isolated cells
    • Milan, Italy
      Urology Department
    Nov 6, 2023

    Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

    Not yet recruiting
    • Bladder Cancer
    • +3 more
    • Geriatric-8 Survey
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma, Perfusion; Complications, Intraoperative Complications Trial

    Recruiting
    • High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
    • +2 more
    • hyperthermic intravesical perfusion
    • Zhengzhou, Henan, China
      BR-PRG
    Sep 15, 2022

    Protocol for Muscle Invasive Urothelial Carcinoma of Urinary

    Recruiting
    • Bladder Cancer
    • terta modal bladder preservation
    • Assiut, Assuit, Egypt
      Assuit university
    Aug 13, 2022

    CXCL5 asValuable Prognostic Marker in Urinary Bladder Urothelial

    Recruiting
    • Urinary Bladder Urothelial Carcinoma
      • Sohag, Egypt
        Faculty of Medicine, Sohag University
      Jul 26, 2022

      Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)

      Not yet recruiting
      • Urothelial Carcinoma Ureter
      • Urothelial Cancer of Renal Pelvis
      • Mitomycin C
      • (no location specified)
      Jul 31, 2023

      Urine DNA Testing for Bladder Cancer in China

      Recruiting
      • Bladder Cancer
      • +3 more
      • Urine DNA methylation analysis
      • medical imaging and/or cystoscopy and/or pathological examination
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Dec 29, 2022

      Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

      Not yet recruiting
      • Advanced Urothelial Carcinoma
      • Boston, Massachusetts
        VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
      Jan 13, 2023

      Intravesical BCG: is the Urinary Bladder Ready to Receive it

      Not yet recruiting
      • Non-Invasive Bladder Urothelial Carcinoma
        • (no location specified)
        Jun 7, 2022

        Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

        Not yet recruiting
        • Muscle Invasive Bladder Urothelial Carcinoma
        • Daily Adaptive External Beam Radiation Therapy
        • Saint Louis, Missouri
          Washington University, St. Louis
        Jan 17, 2023

        Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)

        Active, not recruiting
        • Carcinoma, Transitional Cell
        • San Francisco, California
          University of California, San Francisco
        May 24, 2022

        Primary and Metastatic Tumors in Renal Cell Carcinoma and

        Recruiting
        • Renal Cell Carcinoma
        • +4 more
        • Immune checkpoint inhibitor targeting PD1
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center - Philadelphia
        Jan 27, 2023

        Upper Urinary Tract Urothelial Carcinoma, Bladder Cancer Trial in Vienna (Intravesical Solution)

        Not yet recruiting
        • Upper Urinary Tract Urothelial Carcinoma
        • Bladder Cancer
        • Intravesical Solution
        • Vienna, Austria
        • +1 more
        Mar 31, 2023

        Urothelial Carcinoma Trial in Sohag (Expression of Cortactin anti body)

        Completed
        • Urothelial Carcinoma
        • Expression of Cortactin anti body
        • Sohag, Egypt
          Maisa Hashem Mohammed
        Jul 13, 2022

        Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

        Terminated
        • Bladder Cancer
        • +4 more
        • 3D conformal radiation therapy
        • Atlanta, Georgia
          Emory University Hospital/Winship Cancer Institute
        Feb 14, 2022

        Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • +2 more
        • PDD-TURBT with hexaminolevulinate (Hexvix®)
        • Power Led Saphira (TM) from KARL STORZ
        • (no location specified)
        Jul 24, 2023